sumi.news
Search
Following
Sign in
← Back to news
Markets
RSS Feed
sumi.news
Markets
Follow
Latest
Wed Sep 16
Tue Sep 15
‘Unique Opportunity’: Analyst Says Industrial Giant Wins ‘Lion’s Share’ of AI Chip Contracts at a ‘Mundane Defensive Valuation’
1d
Y
Alluvium Raised Its McKesson (MCK) Stake as Long-Term Growth Expectations Remain Strong
1d
Y
American Express Sees Strong Spending, Raises Revenue Outlook at Conference
1d
Y
Dave Ramsey gives reality check to man facing house debt and wife’s surgery
1d
Y
Dear Tesla Stock Fans, Mark Your Calendars for October 1
1d
Y
Here’s Why This Fund Sold Brown & Brown (BRO)
1d
Y
SandiskCorp. (SNDK): AI Boom Fuels Attractive Storage Market Opportunity
1d
Y
Circle Launches Arc Mainnet With BlackRock, DTCC and Visa as Validators
1d
Y
Vallourec Pipes Up With Another Brazilian Win
1d
Y
CEO of Iconic Railroad Stock Unloads More Than 1,000 Shares
1d
Y
How Is Hewlett Packard Enterprise's Stock Performance Compared to Technology Stocks
1d
Y
Senate is still a toss-up, but Democrats now have slight edge, prediction market traders think
1d
F
Why Is XRP Dropping Today?
1d
Y
What History Reveals About Stock Market Crashes During Presidential Transitions
1d
Y
How I’m Using This Great Barchart Stock Screener to Feel Like the ‘Dr. J’ of Trading
1d
Y
US Politicians Are Buying These Two Stocks
1d
Y
Optics Stocks Rally as Oversold Bounce Takes Hold: Coherent Jumps 6%, Lumentum Climbs 5%, Applied Optoelectronics Advances 3%
1d
Y
Dave & Buster’s (PLAY) Bets On New Leaders To Reverse Its Slide
1d
Y
Comfort Systems USA (FIX) Positioned to Benefit from Accelerated AI Investment
1d
Y
Why Binance Is Dipping Its Toes Into TradFi
1d
Y
New ETF Coverage: KCHP
1d
Y
The Fund Exited Insmed (INSM) After the Investment Thesis Played Out
1d
Y
CVS Trading Well Below Wall Street Targets After Month’s Softening Creates Opening
1d
Y
If You Missed the Nancy Pelosi Rally, Here’s the Case for Buying Bloom Energy Stock Now
2d
Y
PKF O’Connor Davies appoints new partner in commercial tax practice
2d
Y
Apple Watch Rival Garmin Traverses Rocky Road Toward Buy Range
2d
Y
Kroger borrows a key strategy from Costco to lower prices
2d
Y
SpaceX Rises 5% as Starship’s First Orbital Attempt Gets Launch Date; Rocket Lab and AST SpaceMobile Hold Steady
2d
Y
Tesla Tanked This Year: One Of Tech’s Biggest Bulls Says 70% Are On The Horizon
2d
Y
DataMEDS AI Completes $1.5 Million Helomics Acquisition, Expanding into Cancer Diagnostics
2d
Y
CFO Liquidates Shares Valued at More Than $100,000
2d
Y
Nike Is Down 79%. Is It Finally the Ultimate Dividend Stock to Buy and Never Sell?
2d
Y
Dollar Posts Modest Gains Ahead of Expected Fed Rate Hike
2d
Y
Revolution Medicines’ (RVMD) Promising Clinical Results Signal Potential Paradigm Shift
2d
Y
Delixy Holdings Signs Non-Binding LOI for Up to 48% Stake in Kazakhstan’s Sarybulak Oil Field
2d
Y
PCAOB names EY and Deloitte veterans as Audit Practitioner Fellows
2d
Y
Top Economist Warns Odds of a 'Serious' Fed Policy Mistake Are ‘Uncomfortably High and Rising,’ Says Rate Hikes Could Trigger 'Self-Reinforcing' Downturn
2d
Y
Xenetic Biosciences Announces All-Stock Merger with Santersus, Leaving Existing Shareholders with 15% Stake
2d
Y
The Joby Aviation Bull Case Comes Down to One Question
2d
Y
Datasea Expands into AI Elderly Care Robotics Through Strategic Cooperation with Linghang Intelligent
2d
Y
Zhibao Technology Expands Healthcare Data Infrastructure Through Changzhou Insurance Platform Agreement
2d
Y
The Stock Market Looks Shaky Right Now. History Says Dividend Growth Stocks Are Exactly What You Want to Own.
2d
Y
Micro Cap Xenetic Biosciences Expands Therapeutic Platform With Santersus Acquisition
2d
Y
Intel and SK Hynix Stocks Climb on Report of Potential US Chipmaking Partnership
2d
Y
Intel Stock Rises On Talk Of Fab Deal With SK Hynix
2d
Y
Zocdoc is (finally) ready to become the Resy of healthcare
2d
Y
1 Trade to Make Now as the Weakness in Cotton Prices Continues
2d
Y
Is PulteGroup Stock Underperforming the S&P 500?
2d
Y
Billionaire Ray Dalio’s Bridgewater’s and Cathie Wood’s ARK Portfolios: 2 Stocks They Both Own
2d
Y
Medline (MDLN) Slips Amid Broader MedTech Weakness
2d
Y
More →